Sunresin New Materials Co., Ltd. Class A

Sunresin New Materials Co., Ltd. Class A

SSZSE:300487
57.17
CNY
+2.17
(+3.95%)
1.76EPS
38.13P/E
34.13BMarket Cap
Apr 28Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.75
0.85
0.75
0.74
0.97
1.39
2.22
1.97
3.66
3.86
4.96
5.06
5.5
5.97
Basic EPS, GAAP
0.18
0.18
0.13
0.14
0.2
0.32
0.55
0.43
0.95
1.08
1.43
1.56
1.77
1.76
Free Cash Flow per Basic Share
0.14
0.04
-0.12
-0.03
0.07
-0.26
-0.62
0.44
0.65
1.29
1.02
1.1
1.32
- -
Dividend per Share
0.03
0.03
0.04
0.04
0.03
0.04
0.09
0.12
0.16
0.2
0.43
0.69
0.79
0.49
Book Value per Share
1
1.14
1.51
1.59
1.78
2.08
2.71
3.42
4.21
5.42
6.81
7.72
8.65
9.61
Tangible Book Value per Share
0.96
1.06
1.43
1.49
1.7
1.88
2.29
3.02
3.75
4.97
6.33
7.24
8.19
9.06
Basic Weighted Avg Shares
339
336
392
448
456
454
456
469
326
498
501
505
507
507
Sales/Revenue/Turnover
254
286
295
332
444
632
1,012
923
1,195
1,920
2,489
2,554
2,786
3,029
Operating Margin (%)
26.98
23.99
18.35
19.09
21.19
24.19
32.11
28.93
28.34
27.9
34.67
36.32
38.22
38.16
Depreciation Expense
6
8
9
11
20
21
33
90
98
105
129
132
120
- -
Net Income, GAAP
62
60
51
62
93
143
251
202
311
538
717
787
897
892
Effective Tax Rate (%)
12.88
13.8
13.05
13.1
14.23
13.42
12.56
9.8
11.96
12.55
11.73
12.42
13.9
11.4
Profit Margin (%)
24.41
20.87
17.22
18.56
20.98
22.66
24.83
21.9
26.02
28
28.81
30.82
32.2
29.45
Working Capital
237
277
469
442
450
301
477
688
1,098
1,482
2,518
2,918
3,262
3,664
LT Debt
- -
- -
- -
- -
10
10
336
118
102
3
390
432
466
481
Total Equity
336
384
680
722
818
968
1,280
1,673
2,099
2,737
3,456
3,927
4,408
4,891
Return on Invested Capital (%)
18.12
15.83
8.9
8.52
9.51
13.21
16.73
10.89
14.73
21.08
21.27
19.02
19.07
17.5
Return on Capital (%)
20.14
16.03
9.76
8.8
12.1
13.87
18.22
12.64
15.74
21.85
22.17
19.71
19.94
18.65
Return on Common Equity (%)
20.02
16.57
9.56
8.8
12.15
16.29
22.77
13.88
16.66
22.38
23.28
21.42
21.61
19.91

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
50
41
45
LT Borrowings
465
469
479
LT Finance Leases
2
3
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
509
509
509
Market Capitalization
33,379
29,963
34,128

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,993
5,067
5,297
Cash, Cash Equivalents & STI
2,819
2,862
2,909
Accounts Receivable, Net
767
809
876
Inventories
1,174
1,201
1,276
Total Current Liabilities
1,509
1,552
1,633
Payables & Accruals
- -
- -
- -
ST Debt
50
41
45
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.87%
21.6%
12.24%
Free Cash Flow
-71.4%
43.18%
21.17%
Net Income, GAAP
36.58%
36.78%
13.96%
Sales/Revenue/Turnover
27.13%
26.3%
9.08%
Total Cash Common Dividend
48.81%
56.65%
14.68%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
631
664
597
662
2,554
2025
577
671
- -
852
2,786
2026
607
771
798
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.34
0.47
0.38
0.38
1.56
2025
0.38
0.5
- -
0.48
1.77
2026
0.36
0.47
0.44
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.57
0.12
0.69
2025
- -
- -
- -
0.18
0.79
2026
- -
0.01
0.29
- -
- -

Company Description

CEO
Xiao Kang Kou
Full Time Employees
1,618
Sector
Process industries
Industry
Industrial specialties
Address
Sunresin Park Xi'an SA China 710076
IPO Date
Jun 18, 2015
Business
Sunresin New Materials Co., Ltd. (300487.SZ) develops, manufactures and sells adsorption and separation materials, ion exchange resins, chromatographic media and integrated separation equipment including Sepsolut systems; offers technical services and customized solutions for industries such as biopharmaceuticals, life sciences, food processing, pharmaceuticals, plant extraction, hydrometallurgy, wastewater treatment, membrane caustic soda and industrial water treatment. The company produces over 30 series and more than 200 resin types with annual capacity exceeding 50,000 cubic meters, alongside tens of adsorption and separation equipment units. Founded in 2001 and headquartered in Xi'an High-Tech Industrial Development Zone, Shaanxi Province, China, Sunresin operates production bases in Xi'an, Weinan, Hebi and Belgium, with sales reaching over 100 countries globally. Sunresin recently established subsidiaries in Sweden as its life sciences European headquarters with Hans Johansson as general manager, launched Sunresin USA Inc. to enhance North American supply chain capabilities, and announced a USD 160 million investment for a new life sciences industrial park in Pucheng covering 18 hectares to boost chromatography resins and advanced materials production including a GMP facility for APIs and excipients; expanded strategic collaboration with ChiralVision on immobilized enzyme technologies, secured Australian patent for lithium adsorbent, achieved DMF registrations for 10 bioprocess resins supporting antibody, vaccine and gene therapy applications, and reported 2024 revenue of RMB 2.55 billion up 2.6% with net profit of RMB 794 million up 10.1% driven by 33-34% volume growth in hydrometallurgy, life sciences, water treatment and 45% overseas sales increase.